Genetic Study of Early Onset Parkinson's Disease in Cyprus.
Greek-Cypriot Parkinson’s patients
early onset Parkinson’s disease (EOPD)
genetic investigation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
06 Dec 2022
06 Dec 2022
Historique:
received:
09
11
2022
revised:
30
11
2022
accepted:
02
12
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Parkinson's Disease (PD) is a multifactorial neurodegenerative disease characterized by motor and non-motor symptoms. The etiology of PD remains unclear. However, several studies have demonstrated the interplay of genetic, epigenetic, and environmental factors in PD. Early-onset PD (EOPD) is a subgroup of PD diagnosed between the ages of 21 and 50. Population genetic studies have demonstrated great genetic variability amongst EOPD patients. Hence, this study aimed to obtain a genetic landscape of EOPD in the Cypriot population. Greek-Cypriot EOPD patients (
Identifiants
pubmed: 36499697
pii: ijms232315369
doi: 10.3390/ijms232315369
pmc: PMC9739936
pii:
doi:
Substances chimiques
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : TELETHON Cyprus
ID : 33173178
Références
J Biol Chem. 2013 Jul 26;288(30):22019-32
pubmed: 23754282
Semin Neurol. 2011 Nov;31(5):433-40
pubmed: 22266881
Cell Tissue Res. 2018 Jul;373(1):9-20
pubmed: 29536161
J Neurochem. 2016 Oct;139 Suppl 1:59-74
pubmed: 27090875
Aging Clin Exp Res. 2021 May;33(5):1187-1195
pubmed: 32026430
Eur J Neurol. 2014 Jul;21(7):963-8
pubmed: 24313877
Lancet Neurol. 2007 Jul;6(7):652-62
pubmed: 17582365
Ann Neurol. 2020 Oct;88(4):843-850
pubmed: 33045815
Neurosci Lett. 2016 Apr 21;619:168-71
pubmed: 27001088
CMAJ. 2016 Nov 1;188(16):1157-1165
pubmed: 27221269
Mol Neurodegener. 2020 Mar 6;15(1):19
pubmed: 32143659
Brain. 2020 Jul 1;143(7):2220-2234
pubmed: 32613234
Cell Metab. 2018 Oct 2;28(4):605-618.e6
pubmed: 29909971
J Cell Biol. 2010 Apr 19;189(2):211-21
pubmed: 20404107
Hum Genet. 2017 Jan;136(1):13-37
pubmed: 27896429
Neurology. 2004 Feb 10;62(3):389-94
pubmed: 14872018
J Biol Chem. 2010 Sep 17;285(38):29231-8
pubmed: 20630868
Neurogenetics. 2010 Jul;11(3):305-12
pubmed: 20013014
Arch Neurol. 1991 Sep;48(9):903-7
pubmed: 1953412
Arch Neurol. 2008 Jun;65(6):802-8
pubmed: 18541801
Front Neurol. 2020 Jul 28;11:682
pubmed: 32849182
J Biol Chem. 2015 Dec 4;290(49):29542-54
pubmed: 26442590
Biol Pharm Bull. 2004 Aug;27(8):1174-8
pubmed: 15305016
Proc Natl Acad Sci U S A. 2019 Oct 8;116(41):20689-20699
pubmed: 31548400
Neurology. 2008 Jan 1;70(1):43-9
pubmed: 17625105
Parkinsonism Relat Disord. 2006 May;12(4):239-45
pubmed: 16500134
Mov Disord. 2009 Apr 15;24(5):662-6
pubmed: 19205068
Nat Neurosci. 2017 May;20(5):681-689
pubmed: 28288128
Nature. 1997 Aug 28;388(6645):839-40
pubmed: 9278044
Mov Disord. 2017 Jan;32(1):165-169
pubmed: 28124432
Hum Mutat. 2009 Jul;30(7):1054-61
pubmed: 19405094
Ann Neurol. 2003 Oct;54(4):507-13
pubmed: 14520664
Mov Disord. 2022 Aug;37(8):1593-1604
pubmed: 35867623
Science. 2001 Jul 13;293(5528):263-9
pubmed: 11431533
Nat Neurosci. 2013 Sep;16(9):1257-65
pubmed: 23933751
Can J Neurol Sci. 2016 Jan;43(1):113-9
pubmed: 26189779
Ir J Med Sci. 2022 Apr;191(2):901-907
pubmed: 33751372
Biochem Biophys Res Commun. 2008 Dec 19;377(3):975-80
pubmed: 18957282
F1000Res. 2018 Jul 18;7:
pubmed: 30079229
J Cell Biol. 2008 Dec 1;183(5):795-803
pubmed: 19029340
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Lancet Neurol. 2020 Feb;19(2):170-178
pubmed: 31521533
Neurobiol Dis. 2020 Apr;137:104782
pubmed: 31991247
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
J Clin Invest. 2009 Mar;119(3):650-60
pubmed: 19229105
Genet Med. 2017 Oct;19(10):1105-1117
pubmed: 28492532
Cell Death Dis. 2014 Jul 24;5:e1350
pubmed: 25058424
Dis Markers. 2012;32(3):173-8
pubmed: 22377733
Parkinsonism Relat Disord. 2021 May;86:48-51
pubmed: 33845304
Front Genet. 2019 Oct 31;10:1061
pubmed: 31737044
Lancet Neurol. 2018 Nov;17(11):939-953
pubmed: 30287051
Front Neurosci. 2019 Sep 18;13:930
pubmed: 31619944
Genes (Basel). 2022 Mar 07;13(3):
pubmed: 35328025
PLoS One. 2020 Sep 1;15(9):e0238098
pubmed: 32870915
Parkinsonism Relat Disord. 2008 Aug;14(6):509-12
pubmed: 18329316
Hum Genet. 2020 Oct;139(10):1197-1207
pubmed: 32596782
BMC Biochem. 2007 Nov 22;8 Suppl 1:S13
pubmed: 18047737
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Parkinsonism Relat Disord. 2012 Jun;18(5):567-71
pubmed: 22445250
Neurosci Lett. 2015 Sep 14;604:47-51
pubmed: 26240990
Lancet Neurol. 2006 Apr;5(4):355-63
pubmed: 16545752
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a008888
pubmed: 22315721
Proc Natl Acad Sci U S A. 2003 May 13;100(10):5956-61
pubmed: 12719539
Hum Mol Genet. 2006 Jun 1;15(11):1816-25
pubmed: 16632486
Genome Res. 1999 Aug;9(8):677-9
pubmed: 10447503
Mov Disord. 2009 Sep 15;24(12):1811-9
pubmed: 19562770
Mov Disord. 2012 Jul;27(8):1047-51
pubmed: 22777964
J Neural Transm (Vienna). 2017 Aug;124(8):901-905
pubmed: 28150045
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):378-83
pubmed: 19966284
Brain Res. 2010 Oct 28;1358:30-8
pubmed: 20800584
Mov Disord. 2009 Jan 30;24(2):196-203
pubmed: 18973254
Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067
pubmed: 29165669
Neurosci Lett. 2013 Sep 13;551:75-8
pubmed: 23880019
Neurobiol Dis. 2019 Apr;124:230-239
pubmed: 30448284
Cancer Commun (Lond). 2018 Jun 26;38(1):40
pubmed: 29941042
Front Neurosci. 2018 Aug 30;12:612
pubmed: 30214392